Embed Size (px)
Citation preview
Atomoxetine
Azelnidipine
Azilsartan (Base)
Azilsartan Medoxomil Potassium
Bilastine
Brivaracetam
Crisaborole
Colesevelam HCl
Deutetrabenazine
Edoxaban
Elagolix Sodium
Ertugliflozin
Eslicarbazepine acetate
APIs - UNDER DEVELOPMENT
Antipsychotics
Cardiovascular system
Cardiovascular system
Cardiovascular system
Respiratory system
Nervous system
Dermatologicals
Anti-arrhythmics
Nervous system
Anti-arrhythmics
Endometriosis
Anti-diabetic
Anti-epileptic
THERAPEUTIC AREA
Solriamfetol Wakefulness improvement
Tezacaftor Respiratory system
Tofacitinib (Base) Antineoplastic and immunomodulating agents
Items covered by valid patents are not offered or supplied for commercial sale.The patent position should be verified by the buyer.***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***Product filings till June 30, 2019
ACTIVE PHARMACEUTICAL INGREDIENTS
PRODUCT CATALOGUE JULY 2019
E
A
C
B
Adapalene
Alogliptin
Amiodarone
Apixaban
Arformoterol
Azelaic Acid
Bupropion HCl
Butenafine HCl
Cilazapril
Apremilast
Aprepitant
APIs - VALIDATED US CANADA EUROPE CEP JAPAN SouthKorean
Russian China
Canagliflozin
Cilostazol
Colistimethate Na
Dabigatran
Dapagliflozin
Darifenacin
Deferasirox
Deoxycholic Acid
Desloratadine
Dimethyl Fumarate
Dipyridamole
Esomeprazole Mg (Dihydrate)
Esomeprazole Sodium
Esomeprazole Mg (Trihydrate)
Eszopiclone
Atovaquone
Bosentan
D
Dronedarone
Efinaconazole
Dermatologicals
Anti-diabetic
Cardiovascular system
Blood and blood forming organs
Respiratory system
Antineoplastic and immunomodulating agents
Alimentary tract and metabolism
Dermatologicals
Nervous system
Dermatologicals
Cardiovascular system
THERAPEUTIC AREA
Anti-diabetic
Blood and blood forming organs
Genito urinary system and sex hormones
Blood and blood forming organs
Antiinfectives for systemic use
Anti-diabetic
Various
Alimentary tract and metabolism
Respiratory system
Nervous system
Cardiovascular system
Cardiovascular system
Gastroenterology
Gastroenterology
Gastroenterology
Nervous system
Antiparasitic products, insecticides and repellents
Cardiovascular system
Dermatologicals
Items covered by valid patents are not offered or supplied for commercial sale.The patent position should be verified by the buyer.***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***Product filings till June 30, 2019
ACTIVE PHARMACEUTICAL INGREDIENTS
PRODUCT CATALOGUE JULY 2019
O
M
N
P
I
APIs - VALIDATED
F
G
L
Lomitapide
Etoricoxib
Ezetimibe
Fingolimod
Fluconazole
Fosaprepitant
Frovatriptan
Garenoxacin
Glimepiride
Ivacaftor
Lacosamide
Lercanidipine
Levocetirizine
Lifitegrast
Linagliptin
Lithium Carbonate
Imiquimod
Lornoxicam
Luliconazole
Lurasidone
Mirabegron
Moexipril
Nintedanib
Olmesartan
Omeprazole
Oxcarbazepine
Gastroenterology
Nervous system
Perindopril Erbumine
Milnacipran
Gabapentin Enacarbil Anti-epileptic
Loratadine
THERAPEUTIC AREA
Cardiovascular system
Antiinfectives for systemic use
ANTI-DIABETIC
Sensory organs
Pain management
Cardiovascular system
Nervous system
Antiinfectives for systemic use
Alimentary tract and metabolism
Nervous system
Respiratory system
Nervous system
Cardiovascular system
Respiratory system
Anti-diabetic
Nervous system
Dermatologicals
Nervous system
Dermatologicals
Nervous system
Genito urinary system and sex hormones
Nervous system
Cardiovascular system
Respiratory system
Cardiovascular system
Cardiovascular system
Respiratory system
US CANADA EUROPE CEP JAPAN SouthKorean
Russian China
Items covered by valid patents are not offered or supplied for commercial sale.The patent position should be verified by the buyer.***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***Product filings till June 30, 2019
ACTIVE PHARMACEUTICAL INGREDIENTS
PRODUCT CATALOGUE JULY 2019
Olopatadine Sensory organs
Prasugrel Blood and blood forming organs
Rasagiline Tartarate Nervous system
T
Tavaborole
Telmisartan
Teneligliptin
Teriflunomide
Ticagrelor
Tofacitinib Citrate
Topiramate
Trandolapril
Dermatologicals
Cardiovascular system
Anti-diabetic
Nervous system
Blood and blood forming organs
Antineoplastic and immunomodulating agents
Nervous system
Cardiovascular system
Proguanil Antiparasitic products, insecticides and repellents
Pirfenidone
Perindopril Arginine Cardiovascular system
Respiratory system
S
Tadalafil Cardiovascular system
Trospium
Vilazodone
Genito urinary system and sex hormones
Nervous system
Rizatriptan Nervous system
Rasagiline Mesylate Nervous system
Ranolazine Cardiovascular systemR
Riluzole Nervous system
Rivaroxaban Blood and blood forming organs
Roflumilast Respiratory system
Ropinirole Nervous system
Rosuvastatin Calcium Cardiovascular system
Rufinamide Nervous system
Saxagliptin Anti-diabetic
Sertaconazole Nitrate Dermatologicals
Sitagliptin Anti-diabetic
Solifenacin Succinate Genito urinary system and sex hormones
Sucralfate Gastroenterology (antiulcerant)
Terbinafine HCl Antiinfectives for systemic use
V
APIs - VALIDATED THERAPEUTIC AREA US CANADA EUROPE CEP JAPAN SouthKorean
Russian China
ACTIVE PHARMACEUTICAL INGREDIENTS
PRODUCT CATALOGUE JULY 2019
Items covered by valid patents are not offered or supplied for commercial sale.The patent position should be verified by the buyer.***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***Product filings till June 30, 2019
Items covered by valid patents are not offered or supplied for commercial sale.The patent position should be verified by the buyer.***Products under patent are available for R&D use pursuant to 35 U.S.C. 271(e)(1).***Product filings till June 30, 2019
US FDA, MHRA UK,KFDA, PMDA,
WHO-GMP, EDQMand COFEPRIS
US FDA, KFDA,PMDA, WHO-GMP,
EDQM
US FDA,WHO-GMP
Local FDA
Ankleshwar
Dahej
Mohol
Kurkumbh
US, EU, Japanand Emerging
Markets
US, EU, Japanand Emerging
Markets
India andEmergingMarkets
India
MarketsFacilitiesRegulatory
certifications
Z Zolmitriptan
Zolpidem
Nervous system
Nervous system
Zonisamide Nervous system
Voriconazole Antiinfectives for systemic use
APIs - VALIDATED THERAPEUTIC AREA US CANADA EUROPE CEP JAPAN SouthKorean
Russian China
ACTIVE PHARMACEUTICAL INGREDIENTS
PRODUCT CATALOGUE JULY 2019
Vildagliptin Anti-diabetic
